NDA[removed]S-010 Page 3

First Page		Document Content
Date: 2009-03-31 16:04:27 Tropics Antibiotics Sulfones Clofazimine Phenazines Leprostatic agent Dapsone Erythema nodosum Rifampicin Medicine Leprosy Health		NDA[removed]S-010 Page 3 Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 161,37 KB Share Document on Facebook

	Following Candidates are selected for 15 days Summer Trainingat National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra The counselling for dissertation will be held onat 9:00 AM a DocID: 1sB8N - View Document
	National JALMA Institute for Leprosy and Other Mycobacterial Diseases (Indian Council of Medical Research) (Department of Health Research, Ministry of Health & Family Walefare, Government of India) Dr. M Miyazaki Marg, T DocID: 1s4ts - View Document
	The Global Leprosy Strategy 2016–2020 “Accelerating towards a leprosy-free world” was developed through a series of consultations with various stakeholders during 2014 andInputs were provided by national lep DocID: 1rRKV - View Document
	Journal of American Physicians and Surgeons Mission Statement The Journal of American Physicians and Surgeons, the official peer-reviewed journal of the Association of American Physicians DocID: 1q4Cf - View Document
	National JALMA Institute for Leprosy and Other Mycobacterial Diseases (Indian Council of Medical Research) (Department of Health Research, Ministry of Health & Family Walefare, Government of India) Dr. M Miyazaki Marg, T DocID: 1pENZ - View Document